Literature DB >> 26855780

Light-Sensitive Ruthenium Complex-Loaded Cross-linked Polymeric Nanoassemblies for the Treatment of Cancer.

M Dickerson1, B Howerton2, Y Bae2, E Glazer3.   

Abstract

This work focuses on improving the efficacy of photoactivatable Ru complexes for photodynamic therapy by employing cross-linked nanoassemblies (CNAs) as a delivery approach. The effects of complex photoactivation, hydrophobicity, and solution ionic strength and pH on complex loading and release from CNAs were analyzed. The cell cytotoxicity of CNA formulations was similar to free Ru complexes despite reduced or eliminated DNA interactions. The release rate and the amount of each Ru complex released (%) varied inversely with complex hydrophobicity, while the effect of solution ionic strength was dependent on complex hydrophobicity. Premature release of two photoactivatable prodrugs prior to irradiation was believed to account for higher activity in cells studies compared to DNA interaction studies; however, for photostable 1O2 generator-loaded CNAs this cannot explain the high cytotoxicity and lack of DNA interactions because release was incomplete after 48 hrs. The cause remains unclear, but among other possibilities, accelerated release in a cell culture environment may be responsible.

Entities:  

Year:  2015        PMID: 26855780      PMCID: PMC4739781          DOI: 10.1039/C5TB01613D

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  40 in total

Review 1.  Formation and repair of interstrand cross-links in DNA.

Authors:  David M Noll; Tracey McGregor Mason; Paul S Miller
Journal:  Chem Rev       Date:  2006-02       Impact factor: 60.622

Review 2.  Metal complex-DNA interactions: from transcription inhibition to photoactivated cleavage.

Authors:  Leigh Jk Boerner; Jeffrey M Zaleski
Journal:  Curr Opin Chem Biol       Date:  2005-04       Impact factor: 8.822

3.  N-acetylmethionine and biotin as photocleavable protective groups for ruthenium polypyridyl complexes.

Authors:  Roosmarijn E Goldbach; Isabel Rodriguez-Garcia; Joop H van Lenthe; Maxime A Siegler; Sylvestre Bonnet
Journal:  Chemistry       Date:  2011-07-27       Impact factor: 5.236

4.  PEG/RGD-modified magnetic polymeric liposomes for controlled drug release and tumor cell targeting.

Authors:  Wenya Su; Hanjie Wang; Sheng Wang; Zhenyu Liao; Shiyin Kang; Yao Peng; Lei Han; Jin Chang
Journal:  Int J Pharm       Date:  2012-01-14       Impact factor: 5.875

5.  A light-activated metal complex targets both DNA and RNA in a fluorescent in vitro transcription and translation assay.

Authors:  David K Heidary; Edith C Glazer
Journal:  Chembiochem       Date:  2014-01-31       Impact factor: 3.164

Review 6.  Metal based drugs: from serendipity to design.

Authors:  Simon Paul Fricker
Journal:  Dalton Trans       Date:  2007-09-19       Impact factor: 4.390

7.  Correlation between cytotoxicity and DNA binding of polypyridyl ruthenium complexes.

Authors:  O Nováková; J Kaspárková; O Vrána; P M van Vliet; J Reedijk; V Brabec
Journal:  Biochemistry       Date:  1995-09-26       Impact factor: 3.162

8.  Light-activated ruthenium complexes photobind DNA and are cytotoxic in the photodynamic therapy window.

Authors:  Erin Wachter; David K Heidary; Brock S Howerton; Sean Parkin; Edith C Glazer
Journal:  Chem Commun (Camb)       Date:  2012-10-07       Impact factor: 6.222

Review 9.  New metal complexes as potential therapeutics.

Authors:  Christiana Xin Zhang; Stephen J Lippard
Journal:  Curr Opin Chem Biol       Date:  2003-08       Impact factor: 8.822

10.  A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS.

Authors:  L Mu; S S Feng
Journal:  J Control Release       Date:  2003-01-09       Impact factor: 9.776

View more
  12 in total

1.  An Overview Of Photosubstitution Reactions Of Ru(II) Imine Complexes And Their Application In Photobiology And Photodynamic Therapy.

Authors:  Jessica K White; Russell H Schmehl; Claudia Turro
Journal:  Inorganica Chim Acta       Date:  2016-06-18       Impact factor: 2.545

2.  Comparison of Dialysis- and Solvatofluorochromism-Based Methods to Determine Drug Release Rates from Polymer Nanoassemblies.

Authors:  Derek Reichel; Younsoo Bae
Journal:  Pharm Res       Date:  2016-11-21       Impact factor: 4.200

3.  Development of Halofluorochromic Polymer Nanoassemblies for the Potential Detection of Liver Metastatic Colorectal Cancer Tumors Using Experimental and Computational Approaches.

Authors:  Derek Reichel; Louis T Curtis; Elizabeth Ehlman; B Mark Evers; Piotr Rychahou; Hermann B Frieboes; Younsoo Bae
Journal:  Pharm Res       Date:  2017-08-24       Impact factor: 4.200

Review 4.  Critical discussion of the applications of metal complexes for 2-photon photodynamic therapy.

Authors:  Johannes Karges; Hui Chao; Gilles Gasser
Journal:  J Biol Inorg Chem       Date:  2020-11-04       Impact factor: 3.358

Review 5.  The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials.

Authors:  Leli Zeng; Pranav Gupta; Yanglu Chen; Enju Wang; Liangnian Ji; Hui Chao; Zhe-Sheng Chen
Journal:  Chem Soc Rev       Date:  2017-10-02       Impact factor: 54.564

6.  Light-responsive and Protic Ruthenium Compounds Bearing Bathophenanthroline and Dihydroxybipyridine Ligands Achieve Nanomolar Toxicity towards Breast Cancer Cells.

Authors:  Olaitan E Oladipupo; Spenser R Brown; Robert W Lamb; Jessica L Gray; Colin G Cameron; Alexa R DeRegnaucourt; Nicholas A Ward; James Fletcher Hall; Yifei Xu; Courtney M Petersen; Fengrui Qu; Ambar B Shrestha; Matthew K Thompson; Marco Bonizzoni; Charles Edwin Webster; Sherri A McFarland; Yonghyun Kim; Elizabeth T Papish
Journal:  Photochem Photobiol       Date:  2021-11-13       Impact factor: 3.421

7.  Intraligand Excited States Turn a Ruthenium Oligothiophene Complex into a Light-Triggered Ubertoxin with Anticancer Effects in Extreme Hypoxia.

Authors:  John A Roque Iii; Houston D Cole; Patrick C Barrett; Liubov M Lifshits; Rachel O Hodges; Susy Kim; Gagan Deep; Antonio Francés-Monerris; Marta E Alberto; Colin G Cameron; Sherri A McFarland
Journal:  J Am Chem Soc       Date:  2022-04-28       Impact factor: 16.383

8.  Fine-Feature Modifications to Strained Ruthenium Complexes Radically Alter Their Hypoxic Anticancer Activity.

Authors:  Houston D Cole; John A Roque; Liubov M Lifshits; Rachel Hodges; Patrick C Barrett; Dmytro Havrylyuk; David Heidary; Elamparuthi Ramasamy; Colin G Cameron; Edith C Glazer; Sherri A McFarland
Journal:  Photochem Photobiol       Date:  2021-03-28       Impact factor: 3.521

9.  111In-labelled polymeric nanoparticles incorporating a ruthenium-based radiosensitizer for EGFR-targeted combination therapy in oesophageal cancer cells.

Authors:  Martin R Gill; Jyothi U Menon; Paul J Jarman; Joshua Owen; Irini Skaripa-Koukelli; Sarah Able; Jim A Thomas; Robert Carlisle; Katherine A Vallis
Journal:  Nanoscale       Date:  2018-06-07       Impact factor: 8.307

Review 10.  Biological activities of polypyridyl-type ligands: implications for bioinorganic chemistry and light-activated metal complexes.

Authors:  Austin C Hachey; Dmytro Havrylyuk; Edith C Glazer
Journal:  Curr Opin Chem Biol       Date:  2021-03-30       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.